COSMOS Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
COSMOS Pharmaceutical has a total shareholder equity of ¥224.3B and total debt of ¥10.7B, which brings its debt-to-equity ratio to 4.8%. Its total assets and total liabilities are ¥430.2B and ¥206.0B respectively. COSMOS Pharmaceutical's EBIT is ¥31.7B making its interest coverage ratio 1268. It has cash and short-term investments of ¥18.5B.
Key information
4.8%
Debt to equity ratio
JP¥10.70b
Debt
Interest coverage ratio | 1268x |
Cash | JP¥18.45b |
Equity | JP¥224.28b |
Total liabilities | JP¥205.96b |
Total assets | JP¥430.24b |
Financial Position Analysis
Short Term Liabilities: 3349's short term assets (¥116.3B) do not cover its short term liabilities (¥189.5B).
Long Term Liabilities: 3349's short term assets (¥116.3B) exceed its long term liabilities (¥16.4B).
Debt to Equity History and Analysis
Debt Level: 3349 has more cash than its total debt.
Reducing Debt: 3349's debt to equity ratio has reduced from 12.9% to 4.8% over the past 5 years.
Debt Coverage: 3349's debt is well covered by operating cash flow (509.5%).
Interest Coverage: 3349's interest payments on its debt are well covered by EBIT (1268x coverage).